← Eichor
Study identifier: NCT02208869 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Russian Familial Hypercholesterolemia Registry

Condition: Familial Hypercholesterolemia  ·  Sponsor: Russian Cardiology Research and Production Center

PhaseN/A
Planned participants1000
Who can joinAll sexes, 7 Years to 80 Years
Healthy volunteersNo

About this study

True prevalence of FH in the Russian Federation is unknown which leads to low percentage of diagnosed and treated cases. Research is needed to determine the prevalence of FH, specific diagnostic algorithms and optimal treatment strategies. The main aim of the present study is to evaluate the extent to which FH is underdiagnosed and undertreated in the Russian Federation for reduction of cardiovascular risk related to atherosclerosis in the country. As a first step, total cholesterol (TC) and low-density lipoprotein (LDL-C) levels will be determined in a random sample from Moscow population (n=18000). It is expected that TC ≥ 7.5 mmol/L will be detected in 10% of cohort. During 2014, approximately 500 patients will pass through non-invasive clinical examination at the Russian Cardiology Research and Production Center, including patient demographics, past medical history, family history of hypercholesterolemia, physical findings, current lipid-lowering therapies, blood tests, genetic analysis, echocardiography, carotid duplex ultrasound and exercise SPECT imaging in selected cases. On the basis of the Moscow Program four major Federal Medical Centers will be involved, and FH Registry will be created as a national, multi-center initiative to screen FH patients, control their diagnosis and management, and track clinical-reported outcomes over time. Establishment of National Guidelines for the diagnosis and treatment of FH on the basis of these data and implementation those into…

This description comes directly from the study's public registry record.

Talk to the study team

Marat Ezhov, MD, PhD  ·  +79104137499  ·  Marat_Ezhov@mail.ru

Igor Sergienko, MD, DMSc  ·  +79031492253  ·  igorcardio@mail.ru

Always discuss trial participation with your own doctor first.

Locations (5)

Chelyabinsk State Medical AcademyChelyabinsk, RussiaNot Yet Recruiting
EI Chazov National Medical Research Center of CardiologyMoscow, RussiaRecruiting
Novosibirsk Research Institute of Internal Medicine, Institute of Internal Medicine Siberian Branch of the Russian Academy of Medical SciencesNovosibirsk, RussiaNot Yet Recruiting
Saint-Petersburg State University and North-West State Medical University n.a. I.I.MechnikovSaint Petersburg, RussiaNot Yet Recruiting
Samara State Medical UniversitySamara, RussiaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02208869